PE20121537A1 - Combinacion de teobromina con un descongestivo - Google Patents

Combinacion de teobromina con un descongestivo

Info

Publication number
PE20121537A1
PE20121537A1 PE2012000813A PE2012000813A PE20121537A1 PE 20121537 A1 PE20121537 A1 PE 20121537A1 PE 2012000813 A PE2012000813 A PE 2012000813A PE 2012000813 A PE2012000813 A PE 2012000813A PE 20121537 A1 PE20121537 A1 PE 20121537A1
Authority
PE
Peru
Prior art keywords
decongestive
theobromine
combination
composition
synphrine
Prior art date
Application number
PE2012000813A
Other languages
English (en)
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121537A1 publication Critical patent/PE20121537A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2012000813A 2009-12-14 2010-12-14 Combinacion de teobromina con un descongestivo PE20121537A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121537A1 true PE20121537A1 (es) 2012-12-21

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000813A PE20121537A1 (es) 2009-12-14 2010-12-14 Combinacion de teobromina con un descongestivo

Country Status (18)

Country Link
EP (1) EP2512464A1 (ja)
JP (2) JP2013513651A (ja)
CN (2) CN102740843A (ja)
AU (1) AU2010332494B2 (ja)
BR (1) BR112012014161A2 (ja)
CA (1) CA2784214C (ja)
CO (1) CO6541630A2 (ja)
EC (1) ECSP12012132A (ja)
GB (1) GB0921805D0 (ja)
IL (1) IL220383A (ja)
MX (1) MX343222B (ja)
NZ (1) NZ600243A (ja)
PE (1) PE20121537A1 (ja)
RU (1) RU2564904C2 (ja)
SG (2) SG181686A1 (ja)
UA (1) UA105944C2 (ja)
WO (1) WO2011073646A1 (ja)
ZA (1) ZA201204293B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (ja) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd 風邪用咳止め薬
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP4377564B2 (ja) * 2002-05-02 2009-12-02 ロート製薬株式会社 内服用組成物
RU2311919C2 (ru) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Разработка противокашлевой и смягчающей горло травяной композиции
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
CN100518775C (zh) * 2007-03-16 2009-07-29 邓丽菊 一种治疗咳喘的药物组合物及其制剂

Also Published As

Publication number Publication date
EP2512464A1 (en) 2012-10-24
CA2784214A1 (en) 2011-06-23
ZA201204293B (en) 2013-02-27
GB0921805D0 (en) 2010-01-27
CO6541630A2 (es) 2012-10-16
CA2784214C (en) 2018-01-09
WO2011073646A1 (en) 2011-06-23
JP2013513651A (ja) 2013-04-22
IL220383A (en) 2017-01-31
ECSP12012132A (es) 2012-09-28
UA105944C2 (uk) 2014-07-10
CN105816462A (zh) 2016-08-03
CN102740843A (zh) 2012-10-17
MX343222B (es) 2016-10-28
BR112012014161A2 (pt) 2016-05-17
SG10201408377QA (en) 2015-02-27
SG181686A1 (en) 2012-07-30
MX2012006625A (es) 2012-10-05
NZ600243A (en) 2013-07-26
RU2564904C2 (ru) 2015-10-10
IL220383A0 (en) 2012-08-30
RU2012129839A (ru) 2014-01-27
JP2016040279A (ja) 2016-03-24
AU2010332494A1 (en) 2012-06-14
AU2010332494B2 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
CO2017007694A2 (es) Composiciones de bacillus licheniformis rti184 para beneficiar el crecimiento de plantas
PE20141906A1 (es) Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
GT201400043A (es) Imidazopiridazinas sustituidas con amino
CR20150216A (es) Composiciones y métodos para tratar proteinopatías
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
CL2013001982A1 (es) Metodo para reducir los niveles de glucosa y tratar trastornos del metabolismo de la misma; composicion farmaceutica que comprende metformina y otro agente antidiabetico o antiobesidad.
PE20211069A1 (es) Composicion que comprende 5'-metilselenoadenosina, selenoadenosil-l-homocisteina y gama glutamil-metilselenocisteina
PE20150200A1 (es) Formulacion de anticuerpos
AR061772A1 (es) Composicion de alto contenido de ion fluoruro para el cuidado oral y metodo para mantener la actividad anticaries
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
AR092330A1 (es) Composiciones, metodos de absorcion transmucosa y metodo de tratamiento
CR20120357A (es) Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
BR112015000520A2 (pt) agente de espessamento estável com lipase
PE20121538A1 (es) Combinaciones terapeuticas de teobromina y una antihistamina
CL2015002433A1 (es) Imidazopiridazinas sustituidas
PE20140255A1 (es) Tableta dispersable en forma oral
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
CL2015001748A1 (es) Formulaciones antiparasitarias transdermicas
CO6551744A2 (es) Combinación de fármacos con teobromina y su uso en terapia
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.

Legal Events

Date Code Title Description
FC Refusal